We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

15 hedge funds and large institutions have $66.8M invested in Bicycle Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

37.49% more ownership

Funds ownership: 0% → 37.49% (+37%)

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tybourne Capital Management
Hong Kong
+$23.6M
2
SHI
SV Health Investors
Massachusetts
+$23.1M
3
AVA
Atlas Venture Advisors
Massachusetts
+$16.4M
4
ACM
Aquilo Capital Management
California
+$8.89M
5
Victory Capital Management
Victory Capital Management
Texas
+$1.68M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tybourne Capital Management
Hong Kong
$19.7M +$23.6M +1,957,961 New
SHI
2
SV Health Investors
Massachusetts
$19.3M +$23.1M +1,915,274 New
AVA
3
Atlas Venture Advisors
Massachusetts
$13.7M +$16.4M +1,362,696 New
ACM
4
Aquilo Capital Management
California
$7.42M +$8.89M +737,529 New
Victory Capital Management
5
Victory Capital Management
Texas
$1.4M +$1.68M +139,496 New
PC
6
Polar Capital
United Kingdom
$1.31M +$1.57M +130,000 New
LCM
7
Laurion Capital Management
New York
$1.01M +$1.2M +100,000 New
BCM
8
BlueCrest Capital Management
Jersey
$704K +$843K +70,000 New
PCM
9
Pentwater Capital Management
Florida
$642K +$769K +63,822 New
Millennium Management
10
Millennium Management
New York
$537K +$643K +53,360 New
MIM
11
Monashee Investment Management
Massachusetts
$532K +$637K +52,900 New
Norges Bank
12
Norges Bank
Norway
$503K +$602K +50,000 New
UBS Group
13
UBS Group
Switzerland
$17K +$20.7K +1,718 New
CCA
14
Catalyst Capital Advisors
New York
$5K +$5.54K +460 New
TRCT
15
Tower Research Capital (TRC)
New York
– +$12 +1 New

BCYC Hedge Fund Activity: Q2 2019 in Review

15 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2019, worth a combined $66.8M.

Buyers outnumbered sellers: 15 funds opened new BCYC positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Tybourne Capital Management, opening a new position worth an estimated $23.6M.

  • 15 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $66.8M of Bicycle Therapeutics stock for Q2 2019.
  • 15 funds opened new Bicycle Therapeutics positions in Q2 2019 and 0 closed out, a net change of +15 holders.
  • The largest Bicycle Therapeutics buyer in Q2 2019 was Tybourne Capital Management, an estimated $23.6M added.

Based on aggregated 13F filings for Q2 2019.